320580-88-9 Usage
Description
Carbamic acid, [2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI), also known as tert-butyl N-(isopropyl)carbamate, is a chemical compound that is an ester derivative of carbamic acid. It is characterized by its potential applications in various industries due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
Carbamic acid, [2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI) is used as a synthetic intermediate for the production of various drugs. Its role in the synthesis process is crucial for creating a range of pharmaceutical compounds that address different health conditions.
Used in Agricultural Industry:
In the agricultural sector, this compound serves as a synthetic intermediate in the development of pesticides. Its contribution to the formulation of effective pest control agents helps protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
Carbamic acid, [2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI) is utilized as a reagent in organic synthesis. Its properties make it a valuable component in the creation of a variety of organic compounds for research and industrial applications.
Used as a Precursor in Chemical Manufacturing:
Carbamic acid, [2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI) also acts as a precursor in the manufacturing of other chemicals. Its ability to be transformed into different chemical entities makes it a versatile building block in the chemical industry.
Used as a Chelating Agent for Metal Ions:
Research has explored the potential of Carbamic acid, [2-[(1-methylethyl)amino]ethyl]-, 1,1-dimethylethyl ester (9CI) as a chelating agent for metal ions. This application could be significant in various chemical processes where metal ion management is required.
Used as a Stabilizer in Polymer Materials:
Additionally, this compound has been studied for its potential use as a stabilizer in polymer materials. Its ability to enhance the stability and performance of polymers could have implications in material science and engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 320580-88-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,0,5,8 and 0 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 320580-88:
(8*3)+(7*2)+(6*0)+(5*5)+(4*8)+(3*0)+(2*8)+(1*8)=119
119 % 10 = 9
So 320580-88-9 is a valid CAS Registry Number.
320580-88-9Relevant articles and documents
Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors
Yu, Jianjun,Xu, Lei,Hong, Duidui,Zhang, Xiaotuan,Liu, Jieyu,Li, Daqiang,Li, Jia,Zhou, Yubo,Liu, Tao
, p. 543 - 558 (2018/11/10)
A series of novel phenol ether derivatives were designed, synthesized, and evaluated as non-covalent proteasome inhibitors. Most compounds exhibited moderate to excellent proteasome inhibitory activity. In particular, compound 18x proved to be the most po
Highly enantioselective synthesis of 2,3-dihydro-1 H-imidazo[2,1-a isoindol-5(9b H)-ones via catalytic asymmetric intramolecular cascade imidization-nucleophilic addition-lactamization
He, Yuwei,Cheng, Chuyu,Chen, Bin,Duan, Kun,Zhuang, Yue,Yuan, Bo,Zhang, Meisan,Zhou, Yougui,Zhou, Zihong,Su, Yu-Jun,Cao, Rihui,Qiu, Liqin
supporting information, p. 6366 - 6369 (2015/01/16)
Highly enantioselective catalytic asymmetric intramolecular cascade imidization-nucleophilic addition-lactamization of N1-alkylethane-1,2-diamine with methyl 2-formylbenzoate catalyzed by a chiral phosphoric acid represents the first efficient method for the preparation of medicinally interesting chiral 2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-ones with high yields and excellent enantioselectivities. This strategy has been shown to be quite general toward various methyl 2-formylbenzoates.
Preparation of mono Boc-protected unsymmetrical diamines
Li, Hongbo,Hao, Meng-An,Wang, Liping,Liang, Wu,Chen, Kai
experimental part, p. 301 - 307 (2009/12/26)
-
